Destiny Pharma Share Discussion Threads

[nick2412] 28/12/2023 14:43

I would rather they keep any general update until the New Year when it will get more attention. It won't necessarily be material though because anything material has to be released immediately.

[arab3] 28/12/2023 12:16

Spot on with the counting supracat

[supracat] 28/12/2023 12:07

I was expecting some sort of update before year end. So I guess either today or tomorrow is left.

[parvez] 28/12/2023 11:27

Too quiet for any news before the New Year however would not be surprised if it is tipped somewhere

[arab3] 28/12/2023 11:21

Does Someone think there is news before year end ?

[nick2412] 27/12/2023 23:04

A delayed 50,000 buy, above the offer as well at 70.9.

[arab3] 22/12/2023 14:31

Did you enjoy the fun week ?

[mam fach] 22/12/2023 14:29

Cleared out all those that held for a week.
Merry Christmas.
GLA LTH's.

[banshee] 21/12/2023 16:27

Had this one on my watch list for years and just started nibbling a few, not really a fan of bios but this seems to have a lot going for it - as well as good management, which is probably just as important as the quality of the products imo. A lot of good informative posts here and on LSE as well.

The average time for a small player to strike deal in the Biotech industry is around 18 months, so I would not think there was too much to be concerned about here in that regard yet.

[adorling] 21/12/2023 16:27

still 4 days left in 2023 - let's see what happens.....The pain of having sold out just as the "deal announcement is made" and the share price 2-3 bags at least will be a lasting pain for years. Just hold and be patient. Get rich slowly as they say!

[marvelman] 21/12/2023 12:15

TTL

My take is that the new best in class management is eons away from the previous incumbent. Previously a lifestyle existence with shareholders having to pay for it and in no hurry to change the status quo. Now we have a BOD wanting to make things happen.

[captain james t kirk] 21/12/2023 08:03

One of the many attractions of XF-73, aside of the fact that it's vastly superior to the current standard of care Mupirocin, is that the largely already agreed design of the phase 3 trial will enrol a cohort of some 2000 patients and its performance against Mupirocin will be the key benchmark. And this trial will not be short of participants, nor will it take long to reach a conclusion because of XF-73's rapidity of action. This makes the overall package very attractive to potential partners. It's also a completely new class of medicine, with further potential, in dermal and fungal XF-73, plus, I would imagine, possibly others not yet disclosed.
You mention new management and I really do believe it was on the business side of affairs where Destiny fell short in the past. The appointment of Susan Koppy, the re appointment of Sir Nigel Rudd and the replacement of the CEO with Chris Tovey are a major move in the right direction and I'm sure we will soon start to see the fruits of their labours.
I agree there's a constant seller and as you say, not only is the share price holding up well but one also wonders where it will/would be without them. Not long now I suspect.
I firmly believe you will get at least your $1 billion, I just don't believe we will have to wait 6 years to see it.

[ttlance] 20/12/2023 23:42

Feeling is that 80p is the ceiling and will drift lower over the next few months. The longer there is no partnership announcement the more nervous investors will get.

Also there appears to be a relentless seller out there, dumping significant tranches of shares every day. Though the price has held up impressively, despite this.

[ttlance] 20/12/2023 23:38

It’s tricky, this time last year M3 was supposed to bring a significant up front payment, with the company putting the market size as the same as xf73. They’ve now tried to increase this market size to entice potential partners, learning from their failings of M3.

New management have some serious clout but it’s the product that will sell itself at the end of the day. I don’t think a deal will be done until March and the upfront payment is likely to be low, £5m will be good. The business is keeping a tight rein on costs which is good. Annual costs running at circa $7m, they need to strike a good deal for the milestone payments. Anyway I’m here for the next 6 years, prepared to lose all my money but with the hope of the stock hitting $1b market cap in 6 years.

[cyberbub] 20/12/2023 22:12

TTL, what's your projection of the next few months here?

[supracat] 20/12/2023 19:47

I'd take a 500m offer for the co. To a large US Pharma, Here and now. Ie circa 500 pence per share.

[ttlance] 20/12/2023 19:45

Investors getting sucked in here. There will be no partnership deal soon imo, feels like Deja vu, exactly this time last year everyone was expecting a big upfront payment for M3 and it was a damp Squibb, it didn’t materialise. Further funding required as funds run out in feb 2025 so will be going to the market for more funding in August, pressure is on to get a good partnership deal. Company didn’t respond to my question for the milestone payment for starting of M3 trials so appreciate if someone can shed light on this…

[carlisle44] 20/12/2023 17:40

100m more like a steal imo

[cyberbub] 20/12/2023 17:19

Agreed. $100m cap is chump change for a big pharma.

[supracat] 20/12/2023 13:34

I was expecting DP to issue an all encompassing update this week which would include where we are with a deal on XF nasal and an update on XF dermal and spore gen too. I also think a complete sale of the Co to a large global Pharma is an option too, which may be delaying matters communicated to us.

[carlisle44] 20/12/2023 12:20

from RNS 20/09/23:

US government's National Institute, Allergy, and Infectious
Diseases (NIAID) funding an extensive and on-going safety
study of XF-73 dermal. The second and final clinically-enabling
regulatory study is expected to complete by late 2023

Any update chaps? TIA

[arab3] 19/12/2023 22:59

It doesn't worry me at all:-)

[smithie6] 19/12/2023 22:35

"arab3"

Argh, that's a worrying posting name.

Hopefully they don't want to exterminate the rest of us posters !!

:-(

[arab3] 19/12/2023 21:19

I think you have hit the nail on the head there mam fach

[mam fach] 19/12/2023 11:11

Let's hope price doesn't fall back with no news.
This little gem is still under the radar.
GLA